AdvisorShares Investments’s Amedisys AMED Stock Holding History

AdvisorShares Investments’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,795	Closed	-$952K	–	138
2020 Q2	$952K	Buy	+4,795	New	+$894K	0.41%	52

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AdvisorShares Investments's AMED Position: Q3 2020 in Review

AdvisorShares Investments sold out of Amedisys (AMED) in Q3 2020, closing a stake of 4,795 shares — an estimated $952K sold.

AdvisorShares Investments first reported a position in AMED in Q2 2020 and held it in 1 quarter. The position peaked at $952K in Q2 2020. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

AdvisorShares Investments reported no remaining Amedisys position as of Q3 2020 after selling out during the quarter.
AdvisorShares Investments sold 4,795 Amedisys shares in Q3 2020, an estimated $952K.
AdvisorShares Investments first reported a position in Amedisys in Q2 2020 and held it in 1 quarter.
AdvisorShares Investments's Amedisys position peaked at $952K in Q2 2020.
397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on AdvisorShares Investments's 13F filing for Q3 2020, filed 12 Nov 2020.